Bull
$56.20
Scenario price
$61.360
+3.688 (+6.01%)At close
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Establishment Labs Holdings Inc is currently a hold. The stock's current price is $61.67, which is significantly below the analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at 33.78, suggesting it is oversold, and the company has been unprofitable with a forward P/E of 204.08, indicating high valuation risk. The main risk is the insider selling, which has increased by 141.15% over the last month, signaling potential lack of confidence from insiders.
Citi
$92
2026-08-13
Citi
2026-08-13
Price Target
$92
Canaccord
$105
2026-08-07
Canaccord
2026-08-07
Price Target
$105
Mizuho
$105
2026-07-15
Mizuho
2026-07-15
Price Target
$105
Citi
$92
2026-07-08
Citi
2026-07-08
Price Target
$92
BTIG
$90
2026-05-07
BTIG
2026-05-07
Price Target
$90
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Latest Wall Street Rating Updates

Establishment Labs Receives FDA Approval for Expanded Breast Implant Range

Establishment Labs Presents New Clinical Data on Breast Tissue Preservation

GLP-1 Drugs Boost Demand for Breast Augmentation

Global Medical Aesthetics Market Poised for Significant Growth
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is currently a hold. The stock's current price is $61.67, which is significantly below the analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at 33.78, suggesting it is oversold, and the company has been unprofitable with a forward P/E of 204.08, indicating high valuation risk. The main risk is the insider selling, which has increased by 141.15% over the last month, signaling potential lack of confidence from insiders.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.